ORYZON, PALO BIOPHARMA AND AROMICS awarded with funding for JOINT research program

ORYZON, coordinator of the project, announces that the joint project TRION, focused on the discovery and characterization of compounds that inhibit membrane receptors expressed on cancer cells, has received a grant co-funded by FEDER to finance the project, which will have a total budget of 1.4 million Euros. The objective of the project is to bring one compound to the phase of preclinical development.